Characterizing iron deposition in Parkinson's disease using susceptibility-weighted imaging: An in vivo MR study

Brain Research

Volumn 1330, Issue , 2010, Pages 124-130

  Zhang, Jiuquan ^a   Zhang, Yanling ^a   Wang, Jian ^a   Cai, Ping ^a   Luo, Chunxia ^a   Qian, Zhongming ^b   Dai, Yongming ^c   Feng, Hua ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c SIEMENS LTD   (China)

Author keywords

Iron deposition; Parkinson's disease; Susceptibility weighted imaging

Indexed keywords

BIOLOGICAL MARKER; IRON;

ADULT; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE DURATION; FEMALE; GLOBUS PALLIDUS; HUMAN; IMAGE PROCESSING; IN VIVO STUDY; MALE; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; PARKINSON DISEASE; PRIORITY JOURNAL; PUTAMEN; RED NUCLEUS; SUBSTANTIA NIGRA; SUSCEPTIBILITY WEIGHTED IMAGING; THALAMUS; UNIFIED PARKINSON DISEASE RATING SCALE; WHITE MATTER; AGED; BRAIN; HEMISPHERIC DOMINANCE; HOSPITALIZATION; METABOLISM; METHODOLOGY; MIDDLE AGED; TIME;

AGE OF ONSET; AGED; BRAIN; FEMALE; FUNCTIONAL LATERALITY; HUMANS; IRON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 77955905072     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2010.03.036     Document Type: Article

References (35)

1. Atasoy, H.T., Nuyan, O., Tunc, T., Yorubulut, M., Unal, A.E., Inan, L. E., 2004. T2-weighted MRI in Parkinson's disease; substantia nigra pars compacta hypointensity correlates with the clinical scores. Neurol. India 52, 332-337. (Pubitemid 39430186)
2. Bartzokis, C., Cummings, J.L., Markham, C.H., Marmarelis, P.Z., Treciokas, L.J., Tishler, T.A., Marder, S.R., Mintz, J., 1999. MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. Magn. Reson. Imaging 17, 213-222.
3. Bartzokis, C., Tishler, T.A., Lu, P.H., Villablanca, P., Altshuler, L.L., Carter, M., Huang, D., Edwards, N., Mintz, J., 2007. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol. Aging 28, 414-423. (Pubitemid 46177391)
4. Benarroch, E.E., 2009. Brain iron homeostasis and neurodegenerative disease. Neurology 72, 1436-1440.
5. Calne, D.B., 1992. The free radical hypothesis in idiopathic parkinsonism: evidence against it. Ann. Neurol. 32, 799-803.
6. Chen, J.C., Hardy, P.A., Kucharczyk, W., Clauberg, M., Joshi, J.C., Vourlas, A., Dhar, M., Henkelman, R.M., 1993. MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. AJNR Am. J. Neuroradiol. 14, 275-281.
7. Dexter, D.T., Wells, F.R., Agid, F., Agid, Y., Lees, A.J., Jenner, P., Marsden, C.D., 1987. Increased nigral iron content in postmortem parkinsonian brain. Lancet 2, 1219-1220. (Pubitemid 17156630)
8. Dexter, D.T., Carayon, A., Vidailhet, M., Ruberg, M., Agid, F., Agid, Y., Lees, A.J., Wells, F.R., Jenner, P., Marsden, C.D., 1990. Decreased ferritin levels in brain in Parkinson's disease. J. Neurochem. 55, 16-20. (Pubitemid 20187798)
9. Dexter, D.T., Carayon, A., Javoy-Agid, F., Agid, Y., Wells, F.R., Daniel, S.E., Lees, A.J., Jenner, P., Marsden, C.D., 1991. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114 (Pt 4), 1953-1975.
10. Fahn, S., Elton, R.L., 1987. Unified Parkinson's disease rating scale. In: Fahn, S., Marsden, C.D., Goldstein, M., Calne, D.B. (Eds.), Recent Developments in Parkinson's Disease, Vol. 2. Macmillan Healthcare, Florham Park, NJ, pp. 153-163.
11. Gerlach, M., Double, K.L., Youdim, M.B., Riederer, P., 2006. Potential sources of increased iron in the substantia nigra of parkinsonian patients. J. Neural Transm. 133-142 (Suppl.). (Pubitemid 44622190)
12. Griffiths, P.D., Crossman, A.R., 1993. Distribution of iron in the basal ganglia and neocortex in postmortem tissue in Parkinson's disease and Alzheimer's disease. Dementia 4, 61-65.
13. Haacke, E.M., Xu, Y., Cheng, Y.C., Reichenbach, J.R., 2004. Susceptibility weighted imaging (SWI). Magn. Reson. Med. 52, 612-618.
14. Haacke, E.M., Ayaz, M., Khan, A., Manova, E.S., Krishnamurthy, B., Gollapalli, L., Ciulla, C., Kim, I., Petersen, F., Kirsch, W., 2007a. Establishing a baseline phase behavior in magnetic resonance imaging to determine normal vs. abnormal iron content in the brain. J. Magn. Reson. Imaging 26, 256-264.
15. Haacke, E.M., Filleti, C.L., Gattu, R., Ciulla, C., Al-Bashir, A., Suryanarayanan, K., Li, M., Latif, Z., DelProposto, Z., Sehgal, V., Li, T., Torquato, V., Kanaparti, R., Jiang, J., Neelavalli, J., 2007b. New algorithm for quantifying vascular changes in dynamic contrast-enhanced MRI independent of absolute T1 values. Magn. Reson. Med. 58, 463-472.
16. Hallgren, B., Sourander, P., 1958. The effect of age on the non-haemin iron in the human brain. J. Neurochem. 3, 41-51.
17. Hughes, A.J., Daniel, S.E., Kilford, L., Lees, A.J., 1992. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J. Neurol. Neurosurg. Psychiatry 55, 181-184.
18. Ke, Y., Qian, Z.M., 2003. Iron misregulation in the brain: a primary cause of neurodegenerative disorders. Lancet Neurol. 2, 246-253. (Pubitemid 37443312)
19. Ke, Y., Qian, Z.M., 2007. Brain iron metabolism: neurobiology and neurochemistry. Prog. Neurobiol. 83, 149-173.
20. Kosta, P., Argyropoulou, M.I., Markoula, S., Konitsiotis, S., 2006. MRI evaluation of the basal ganglia size and iron content in patients with Parkinson's disease. J. Neurol. 253, 26-32. (Pubitemid 43157384)
21. Martin, W.R., Wieler, M., Gee, M., 2008. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status. Neurology 70, 1411-1417. (Pubitemid 351521933)
22. Michaeli, S., Oz, G., Sorce, D.J., Garwood, M., Ugurbil, K., Majestic, S., Tuite, P., 2007. Assessment of brain iron and neuronal integrity in patients with Parkinson's disease using novel MRI contrasts. Mov. Disord. 22, 334-340.
23. Mondino, F., Filippi, P., Magliola, U., Duca, S., 2002. Magnetic resonance relaxometry in Parkinson's disease. Neurol. Sci. 23 (Suppl 2), S87-S88.
24. Oakley, A.E., Collingwood, J.F., Dobson, J., Love, C., Perrott, H.R., Edwardson, J.A., Elstner, M., Morris, C.M., 2007. Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 68, 1820-1825. (Pubitemid 46791395)
25. Ogg, R.J., Langston, J.W., Haacke, E.M., Steen, R.G., Taylor J.S., 1999. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn. Reson. Imaging 17, 1141-1148.
26. Qian, Z.M., Shen, X., 2001. Brain iron transport and neurodegeneration. Trends Mol. Med. 7, 103-108.
27. Rouault, T.A., 2001. Iron on the brain. Nat. Genet. 28, 299-300.
28. Salazar, J., Mena, N., Hunot, S., Prigent, A., Alvarez-Fischer, D., Arredondo, M., Duyckaerts, C., Sazdovitch, V., Zhao, L., Garrick, L.M., Nunez, M.T., Garrick, M.D., Raisman-Vozari, R., Hirsch, E.C., 2008. Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc. Natl. Acad. Sci. U. S. A. 105, 18578-18583.
29. Sehgal, V., Delproposto, Z., Haacke, E.M., Tong, K.A., Wycliffe, N., Kido, D.K., Xu, Y., Neelavalli, J., Haddar, D., Reichenbach, J.R., 2005. Clinical applications of neuroimaging with susceptibility-weighted imaging. J. Magn. Reson. Imaging 22, 439-450.
30. Sitburana, O., Ondo, W.G., 2009. Brain magnetic resonance imaging (MRI) in parkinsonian disorders. Parkinsonism Relat. Disord. 15, 165-174.
31. Sohmiya, M., Tanaka, M., Aihara, Y., Okamoto, K., 2004. Structural changes in the midbrain with aging and Parkinson's disease: an MRI study. Neurobiol. Aging 25, 449-453. (Pubitemid 38317342)
32. Wallis, L.I., Paley, M.N., Graham, J.M., Grunewald, R.A., Wignall, E.L., Joy, H.M., Griffiths, P.D., 2008. MRI assessment of basal ganglia iron deposition in Parkinson's disease. J. Magn. Reson. Imaging 28, 1061-1067.
33. Xu, X., Wang, Q, Zhang, M., 2008. Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study. Neuroimage 40, 35-42.
34. Yantiri, F., Andersen, J.K., 1999. The role of iron in Parkinson disease and 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine toxicity. IUBMB Life 48, 139-141.
35. Zecca, L., Youdim, M.B., Riederer, P., Connor, J.R., Crichton, R.R., 2004. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863-873.